Skip to main content

ADVERTISEMENT

Nanco Hefting, MSc

Objective: The Orion study (NCT01360866) evaluated the long-term safety, tolerability, and therapeutic effect of brexpiprazole (0.5–3 mg/day), as adjunct to antidepressant treatment, in a...
03/01/2019